Skip to main content
. 2016 Jun 23;11(6):e0157631. doi: 10.1371/journal.pone.0157631

Table 2. Clinical manifestations at notification (n = 43347).

Clinical manifestation Total n (%) Alive n (%), n = 43255 Dead, n (%), n = 92
Body or joint ache 37209 (85.8) 37134 (85.8) 73 (79.3)
Headache 32913 (75.9) 32849 (75.9) 63 (68.5)
Nausea and/or vomiting 14917 (34.4) 14867 (34.4) 47 (51.1)
Abdominal symptoms 12489 (28.8) 12455 (28.8) 31 (33.7)
Rash 6700 (15.5) 6689 (15.5) 11 (12.0)
Suborbital pain 1655 (3.8) 1653 (3.8) 2 (2.2)
Bleeding 864 (2.0) 856 (2.0) 7 (7.6)
Abdominal pain or tenderness 805 (1.9) 801 (1.9) 3 (3.3)
Lethargy and/or restlessness 316 (0.7) 310 (0.7) 6 (6.5)
Persistent vomiting 64 (0.1) 62 (0.1) 2 (2.2)
Severe plasma leakage 27 (0.1) 25 (0.1) 2 (2.2)
Liver enlargement 2cm 5 (<0.1) 5 (<0.1)) 0 (0.0)
Shock 4 (<0.1) 1 (<0.1) 3 (3.3)
Clinical fluid accumulation 2 (<0.1) 2 (<0.1) 0 (0.0)
Organ failure (kidney/liver/central nervous system/heart) 2 (<0.1) 1 (<0.1) 1 (1.1)
Severe bleeding 0 (0.0) 0 (0.0) 0 (0.0)